Nubia de Cassia Almeida Queiroz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nubia de Cassia Almeida Queiroz has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Humberto Moreira Spindola
Chemical, Biological and Agricultural Research Center (CPQBA), University of Campinas (UNICAMP), 13083-970 Campinas, SP, Brazil
2 shared publications - Mary Ann Foglio
Faculty of Pharmaceutical Sciences, Universidade Estadual de Campinas, Campinas 13083-859, SP, Brazil
2 shared publications - Fabiana R. Nonato
Chemical, Biological and Agricultural Pluridisciplinary Research Center (CPQBA), University of Campinas-UNICAMP, Paulínia-SP 13148-218, Brazil
1 shared publication - Fabricio de Faveri Favero
CPQBA, University of Campinas, P,O, Box 6171, 13083-970 Campinas, SP, Brazil.
1 shared publication - Giovanna Barbarini Longato
Research Laboratory in Molecular Pharmacology of Bioactive Compounds, Postgraduate Program in Health Sciences, São Francisco University (USF–Universidade São Francisco), Bragança Paulista 12916-900, SP, Brazil
1 shared publication - Ilza Maria de Oliveira Sousa
Faculty of Pharmaceutical Sciences, State University of Campinas, Sao Paulo, Brazil, unicamp.br
1 shared publication
Latest Publications
- Open Access
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108693
Pterodon pubescens and Cordia verbenacea association promotes a synergistic response in antinociceptive model and improves the anti-inflammatory results in animal models
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108693
Open AccessPterodon pubescens and Cordia verbenacea association promotes a synergistic response in antinociceptive model and improves the anti-inflammatory results in animal models
- Open Access
- 28 July 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 1-11
Artemisia annua L.: evidence of sesquiterpene lactones’ fraction antinociceptive activity
Artemisia annua L. has been used for many centuries in Chinese traditional medicine. Artemisinin, the active principle was first isolated and identified in the 1970s becoming the global back bone to the fight against malaria. Our research group previously developed an economic and ecological friendly process to obtain this compound. In the pursuit to also exploit the residue generated throughout the process we further evaluated the pharmacological potential of that extract. The alcoholic crude extract after artemisinin precipitation maintained an enriched sesquiterpene lactones content with residue artemisinin (1.72%) and deoxyartemisinin (0.31%), used as chemical markers for this sample. This study evaluated the pharmacological potential of the enriched sesquiterpene lactone fraction (Lac-FR) on different nociceptive and inflammatory experimental animal models. Previous findings on the biological properties of lactones obtained from natural products permitted us to explore the antinociceptive activities of these compounds based on in vivo chemical-induced behavioral assays. The enriched sesquiterpene lactone fraction (Lac-FR) was administrated by intraperitoneal injection producing a relevant reduction in the reaction time of the animals in both phases of the formalin test, significantly reduced the sensitivity to mechanical allodynia stimulus, reduced the paw edema caused by carrageenan injection and promoted high antinociceptive activity in tail flick model suggesting relationship with the opioid system. Further studies are being undertaken to elucidate the active components involved with the antinociceptive activity as well as evaluation of synergy effect that is seen by combination of substances that is greater than would be expected from consideration of individual contributions. For the first time, results presented herein provided consistent data to support the potential use of these lactones for pain relief as revealed by chemical-induced nociception assays in mice.
- 28 July 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 1-11
Open AccessArtemisia annua L.: evidence of sesquiterpene lactones’ fraction antinociceptive activity
Artemisia annua L. has been used for many centuries in Chinese traditional medicine. Artemisinin, the active principle was first isolated and identified in the 1970s becoming the global back bone to the fight against malaria. Our research group previously developed an economic and ecological friendly process to obtain this compound. In the pursuit to also exploit the residue generated throughout the process we further evaluated the pharmacological potential of that extract. The alcoholic crude extract after artemisinin precipitation maintained an enriched sesquiterpene lactones content with residue artemisinin (1.72%) and deoxyartemisinin (0.31%), used as chemical markers for this sample. This study evaluated the pharmacological potential of the enriched sesquiterpene lactone fraction (Lac-FR) on different nociceptive and inflammatory experimental animal models. Previous findings on the biological properties of lactones obtained from natural products permitted us to explore the antinociceptive activities of these compounds based on in vivo chemical-induced behavioral assays. The enriched sesquiterpene lactone fraction (Lac-FR) was administrated by intraperitoneal injection producing a relevant reduction in the reaction time of the animals in both phases of the formalin test, significantly reduced the sensitivity to mechanical allodynia stimulus, reduced the paw edema caused by carrageenan injection and promoted high antinociceptive activity in tail flick model suggesting relationship with the opioid system. Further studies are being undertaken to elucidate the active components involved with the antinociceptive activity as well as evaluation of synergy effect that is seen by combination of substances that is greater than would be expected from consideration of individual contributions. For the first time, results presented herein provided consistent data to support the potential use of these lactones for pain relief as revealed by chemical-induced nociception assays in mice.